Stock Split Decision (Par Value 500 KRW, 5:1 Merge, Schedule Change)


  • Purpose of stock split: stabilize stock price and enhance corporate value by maintaining appropriate number of outstanding shares.
  • Merge ratio: from par value 100 KRW to 500 KRW per share, 5:1 merge (total shares from 27,887,050 to 5,577,410).
  • Schedule change: due to correction of simple clerical error after consultation with relevant authorities, trading suspension end date changed from 2026-05-14 to 2026-05-18, and new stock listing date from 2026-05-15 to 2026-05-19.
  • This stock split is not a capital reduction; no decrease in capital.
  • Fractional shares (less than 1 share) will be paid in cash based on closing price on the first listing day.
ADVERTISEMENT (250px+)

KOSDAQ Filing Information


  • Filing: [Correction of Description] Decision on Stock Consolidation
  • Company: KMPHARMACEUTICAL (225430)
  • Submission: KMPHARMACEUTICAL Co.,Ltd.
  • Receipt: 05-08-2026
  • Under KRX KOSDAQ Market Division